levodopa has been researched along with Atrophy, Muscle in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kwak, YT; Yang, Y | 1 |
Menkes, DL; Silvers, DS | 1 |
Lochner, P; Nardone, R; Tezzon, F | 1 |
Amanova, ZN; Badalian, LO; Temin, PA | 1 |
Lang, AE | 1 |
Bertolasi, L; Costa, B; Fiaschi, A; Zanette, G | 1 |
Kurisaki, H; Mizuno, T | 1 |
Bressman, SB; Ford, B; Greene, PE; Hyland, K | 1 |
Bannister, R; Mackay, AV; Quik, M; Spokes, EG | 1 |
Abbott, RJ; D'Costa, DF; Millac, PA; Pye, IF | 1 |
1 review(s) available for levodopa and Atrophy, Muscle
Article | Year |
---|---|
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed | 1995 |
9 other study(ies) available for levodopa and Atrophy, Muscle
Article | Year |
---|---|
Hemiparkinsonism-hemiatrophy syndrome with Alzheimer's disease.
Topics: Alzheimer Disease; Antiparkinson Agents; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Positron-Emission Tomography; Syndrome | 2015 |
Hemibody mirror movements in hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Arm; Electromyography; Facial Muscles; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Contraction; Muscle, Skeletal; Muscular Atrophy; Parkinsonian Disorders; Peripheral Nervous System Diseases; Syndrome; Treatment Outcome | 2009 |
Hemiparkinson-hemiatrophy syndrome: a transcranial magnetic stimulation study.
Topics: Antiparkinson Agents; Diagnosis, Differential; Electric Stimulation; Female; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Parkinson Disease; Predictive Value of Tests; Syndrome; Transcranial Magnetic Stimulation | 2003 |
[Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
Topics: Adolescent; Adult; Carbidopa; Catecholamines; Child; Child, Preschool; Drug Combinations; Humans; Levodopa; Male; Muscular Atrophy; Muscular Dystrophies | 1984 |
Hemiparkinsonism-hemiatrophy syndrome: neuroradiological and neurophysiological findings.
Topics: Adult; Cerebral Infarction; Evoked Potentials, Somatosensory; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Reaction Time; Syndrome | 1994 |
[A case of multiple system atrophy presenting a regular involuntary movement of the neck muscles synchronous with respiration].
Topics: Amantadine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Neck Muscles; Respiration; Trihexyphenidyl | 1993 |
Parkinsonism, dystonia, and hemiatrophy.
Topics: Adolescent; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Child; Child, Preschool; Dominance, Cerebral; Drug Therapy, Combination; Dystonia; Humans; Infant; Infant, Newborn; Levodopa; Magnetic Resonance Imaging; Muscular Atrophy; Neurologic Examination; Parkinson Disease; Putamen; Treatment Outcome | 2000 |
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Topics: Binding Sites; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Frontal Lobe; Humans; Levodopa; Muscular Atrophy; Neuromuscular Diseases; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Syndrome | 1979 |
The apomorphine test in parkinsonian syndromes.
Topics: Aged; Apomorphine; Diagnosis, Differential; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Muscular Atrophy; Neurologic Examination; Olivopontocerebellar Atrophies; Parkinson Disease; Parkinson Disease, Secondary; Prognosis; Supranuclear Palsy, Progressive | 1991 |